dc.contributor.author | Tuncer, Seref Bugra) | |
dc.contributor.author | Celik, Betul | |
dc.contributor.author | Erciyas, Seda Kilic | |
dc.contributor.author | Erdogan, Ozge Sukruoglu | |
dc.contributor.author | Pasin, Ozge | |
dc.contributor.author | Avsar, Mukaddes | |
dc.contributor.author | Gultaslar, Busra Kurt | |
dc.contributor.author | Ghafour, Arash Adamnejad | |
dc.contributor.author | Uyaroglu, Gamze | |
dc.contributor.author | Odemis, Demet Akdeniz | |
dc.contributor.author | Yazici, Hulya | |
dc.date.accessioned | 2024-03-13T12:08:23Z | |
dc.date.available | 2024-03-13T12:08:23Z | |
dc.date.issued | 2024 | en_US |
dc.identifier.citation | Tuncer, S. B., Celik, B., Erciyas, S. K., Erdogan, O. S., Pasin, O., Avsar, M., ... & Odemis, D. A. (2024). Aberrant miR-3135b and miR-1273g-3p expression in the peripheral blood samples of BRCA1/2 (±) ovarian cancer patients. Heliyon, 10(1). | en_US |
dc.identifier.issn | 24058440 | |
dc.identifier.uri | https://doi.org/10.1016/j.heliyon.2023.e23876 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12294/4079 | |
dc.description.abstract | Ovarian cancer (OC) ranks as the eighth most prevalent malignancy among women globally. The short non-coding RNA molecules, microRNAs (miRNAs) target multiple mRNAs and regulate the gene expression. Here in this study, we aimed to validate miR-3135b and miR-1273g-3p as novel biomarkers for prognostic and diagnostic factor OC. After RNA isolation, we analyzed the miR-3135b and miR-1273g-3p expression in peripheral blood samples derived from 150 OC patients. Subsequently, we compared their expression levels with 100 healthy controls. The differences of miR-3135b and miR-1273g-3p expression were detected using the Quantitative Real Time-PCR (qRT-PCR) technique following miRNA-specific cDNA synthesis pursing miRNA separation. The miR-3135b and miR-1273g-3p were higher in OC patients who tested positive for BRCA1/2 compared to BRCA-negative patients, and healthy cases. The level of miR-3135b demonstrated a roughly 4.82-fold increase in OC patients in comparison to the healthy cases, while miR-1273g-3p expression exhibited a roughly 6.77-fold increase. The receiver operating characteristic (ROC) analysis has demonstrated the potential of miR-3135b and miR-1273g-3p as markers for distinguishing between OC patients and healthy controls. The higher expressions of miR-3135b and miR-1273g-3p could be associated with OC development. Moreover, miR-3135b may have a diagnostic potential and miR-1273g-3p may have both diagnostic and prognostic potential in OC cell differentiation. The string analysis has revealed an association between miR-1273g-3p and the MDM2 gene, suggesting a potential link to tumor formation through the proteasomal degradation of the TP53 tumor suppressor gene. Additionally, the analysis indicates an association of miR-1273g-3p with CHEK1, a gene involved in checkpoint-mediated cell cycle arrest. String analysis also indicates that miR-3135b is associated with the MAPK1 gene, causing activation of the oncogenesis cascade. In conclusion, miR-1273g-3p, and miR-3135b exhibit significant potential as diagnostic markers. However, further research is needed to comprehensively investigate these miRNAs diagnostic and predictive characteristics in a larger cohort. © 2023 The Authors | en_US |
dc.language.iso | eng | en_US |
dc.publisher | Elsevier Ltd | en_US |
dc.relation.ispartof | HELIYON | en_US |
dc.identifier.doi | 10.1016/j.heliyon.2023.e23876 | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Biomarker | en_US |
dc.subject | MiR-1273g-3p | en_US |
dc.subject | Mir-3135b | en_US |
dc.subject | MiRNA | en_US |
dc.subject | Ovarian Cancer | en_US |
dc.title | Aberrant miR-3135b and miR-1273g-3p expression in the peripheral blood samples of BRCA1/2 (±) ovarian cancer patients | en_US |
dc.type | article | en_US |
dc.department | Tıp Fakültesi, Temel Tıp Bilimleri Bölümü | en_US |
dc.authorid | 0000-0002-8919-0482 | en_US |
dc.identifier.volume | 10 | en_US |
dc.identifier.issue | 1 | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.institutionauthor | Yazici, Hulya | |
dc.authorwosid | GSK-8744-2022 | en_US |
dc.authorscopusid | 7102511789 | en_US |
dc.identifier.wosquality | Q2 | en_US |
dc.identifier.wos | WOS:001166116100001 | en_US |
dc.identifier.scopus | 2-s2.0-85182420260 | en_US |
dc.identifier.pmid | 38234891 | en_US |